ReviewFrontiers in clinical diabetes and healthcare2023

GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder.

Eleonora Panfili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.